A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Clinical trial NCT05754957 · COMPLETED
Trial details
- NCT number
- NCT05754957
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-07
- Primary completion
- 2026-02-06
- Enrollment
- 14194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.